Spark Therapeutics Gene Therapy for Blindness Moves Forward With FDA – Philadelphia magazine
Philadelphia magazine |
Spark Therapeutics Gene Therapy for Blindness Moves Forward With FDA
Philadelphia magazine There's a greater chance now than ever before that the Food and Drug Administration's first two approved gene therapies will both come from Philadelphia. This week, the FDA granted “priority review” status to Spark Therapeutics' biologics license … |
